Karremann, M., Kohl, N., Kulozik, A., & Dürken, M. (2017). Haematological malignancies following temozolomide treatment for paediatric high-grade glioma. European journal of cancer, 81, . https://doi.org/10.1016/j.ejca.2017.04.023
Chicago Style (17th ed.) CitationKarremann, Michael, Nadja Kohl, Andreas Kulozik, and Matthias Dürken. "Haematological Malignancies Following Temozolomide Treatment for Paediatric High-grade Glioma." European Journal of Cancer 81 (2017). https://doi.org/10.1016/j.ejca.2017.04.023.
MLA (9th ed.) CitationKarremann, Michael, et al. "Haematological Malignancies Following Temozolomide Treatment for Paediatric High-grade Glioma." European Journal of Cancer, vol. 81, 2017, https://doi.org/10.1016/j.ejca.2017.04.023.
Warning: These citations may not always be 100% accurate.